Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey.
Ali SabbaghJessica WeissBouchra TawkMohammed A MohammedHasan AbdulbakiFabio Ynoe de MoraesSurbhi GroverMei Ling YapEduardo ZubizarretaYolande LievensDanielle RodinOsama MohamadPublished in: JCO global oncology (2023)
Hypofractionation preference varies by indication and World Bank income group, with greater acceptance among providers in HICs for all indications. These results provide a basis for targeted interventions to increase provider acceptance of this treatment modality.